We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 03. 09. | After market close (AMC) | $1.38 | — | — | $742.2M | — | Scheduled |
| FY2026 Q3 | 2025. 01. 31. | Time TBD | — | $3.4 | — | — | $2.04B | Reported |
| FY2026 Q2 | 2024. 10. 31. | Time TBD | — | $2.3 | — | — | $1.36B | Reported |
| FY2026 Q1 | 2024. 07. 31. | Time TBD | — | $1.17 | — | — | $682.76M | Reported |
Consensus PT $75.5 · 4 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 10. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 03. 11. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
Compare a firm's past rating changes and its actions on other stocks in the same sector.